Add Formweb to your mobile device
Search results for:
norethindrone-ethinyl estradiol
norethindrone-ethinyl estradiol
- Hazardous Drugs Handling Guide (Group 2: Non-Antineoplastic)
- Cell Status In-Cell HD
- Exceptions / Designators Formulary restricted to 1/35 combination only. Triphasic formulation has been removed from formulary. Pharmacy not to stock or dispense packs with 21 tablets and no placebo.
Brand names: ALYACEN 1/35, NORTREL, NYLIA 1/35, PIRMELLA 1/35
| Form | Strength | |
|---|---|---|
| TABLET, ORAL | 1 mg-35 mcg |
Last updated: Nov. 16, 2023
- In-Cell HD
- Black Box Warning: Cigarette smoking; risk of cardiovascular disease
MAY 2022 P&T MINUTES
APRIL 2013 P&T MINUTES